Article
Refine
Year of publication
Institute
- Fachbereich Medizintechnik und Technomathematik (1591)
- Fachbereich Wirtschaftswissenschaften (705)
- Fachbereich Elektrotechnik und Informationstechnik (638)
- Fachbereich Energietechnik (609)
- Fachbereich Chemie und Biotechnologie (602)
- INB - Institut für Nano- und Biotechnologien (542)
- Fachbereich Maschinenbau und Mechatronik (484)
- IfB - Institut für Bioengineering (449)
- Fachbereich Luft- und Raumfahrttechnik (379)
- Fachbereich Bauingenieurwesen (333)
- Solar-Institut Jülich (107)
- Fachbereich Architektur (79)
- Fachbereich Gestaltung (58)
- ECSM European Center for Sustainable Mobility (43)
- ZHQ - Bereich Hochschuldidaktik und Evaluation (42)
- Nowum-Energy (36)
- Sonstiges (23)
- Institut fuer Angewandte Polymerchemie (20)
- Freshman Institute (18)
- MASKOR Institut für Mobile Autonome Systeme und Kognitive Robotik (16)
- IBB - Institut für Baustoffe und Baukonstruktionen (10)
- Arbeitsstelle fuer Hochschuldidaktik und Studienberatung (3)
- IMP - Institut für Mikrowellen- und Plasmatechnik (3)
- Verwaltung (3)
- FH Aachen (2)
- Kommission für Forschung und Entwicklung (1)
- Kommission für Planung und Finanzen (1)
Language
Document Type
- Article (5644) (remove)
Keywords
- Einspielen <Werkstoff> (7)
- Multimediamarkt (6)
- Rapid prototyping (5)
- avalanche (5)
- Earthquake (4)
- FEM (4)
- Finite-Elemente-Methode (4)
- LAPS (4)
- Rapid Prototyping (4)
- biosensors (4)
Breast cancer resistance protein (BCRP) is expressed in various tissues, such as the gut, liver, kidney and blood brain barrier (BBB), where it mediates the unidirectional transport of substrates to the apical/luminal side of polarized cells. Thereby BCRP acts as an efflux pump, mediating the elimination or restricting the entry of endogenous compounds or xenobiotics into tissues and it plays important roles in drug disposition, efficacy and safety. Bcrp knockout mice (Bcrp−/−) have been used widely to study the role of this transporter in limiting intestinal absorption and brain penetration of substrate compounds. Here we describe the first generation and characterization of a mouse line humanized for BCRP (hBCRP), in which the mouse coding sequence from the start to stop codon was replaced with the corresponding human genomic region, such that the human transporter is expressed under control of the murine Bcrp promoter. We demonstrate robust human and loss of mouse BCRP/Bcrp mRNA and protein expression in the hBCRP mice and the absence of major compensatory changes in the expression of other genes involved in drug metabolism and disposition. Pharmacokinetic and brain distribution studies with several BCRP probe substrates confirmed the functional activity of the human transporter in these mice. Furthermore, we provide practical examples for the use of hBCRP mice to study drug-drug interactions (DDIs). The hBCRP mouse is a promising model to study the in vivo role of human BCRP in limiting absorption and BBB penetration of substrate compounds and to investigate clinically relevant DDIs involving BCRP.
Superparamagnetic iron oxide nanoparticles (SPION) are extensively used for magnetic resonance imaging (MRI) and magnetic particle imaging (MPI), as well as for magnetic fluid hyperthermia (MFH). We here describe a sequential centrifugation protocol to obtain SPION with well-defined sizes from a polydisperse SPION starting formulation, synthesized using the routinely employed co-precipitation technique. Transmission electron microscopy, dynamic light scattering and nanoparticle tracking analyses show that the SPION fractions obtained upon size-isolation are well-defined and almost monodisperse. MRI, MPI and MFH analyses demonstrate improved imaging and hyperthermia performance for size-isolated SPION as compared to the polydisperse starting mixture, as well as to commercial and clinically used iron oxide nanoparticle formulations, such as Resovist® and Sinerem®. The size-isolation protocol presented here may help to identify SPION with optimal properties for diagnostic, therapeutic and theranostic applications.